Will Be Looking At Some Inorganic Growth Opportunities In The Southern Market: Dr Lal PathLabs

Dr Lal Pathlabs MD Explains How Co Expects To Beat Last Year's Growth Without Price IncreaseПодробнее

Tested About 10 Milion Patients Last Year: Dr Lal PathLabsПодробнее

Why is Dr Lal Pathlabs Share Price Falling? Buying Opportunity? HOLD or SELL?Подробнее

Dr Lal Pathlabs: Improvement In Revenue Mix, Company's Plan To Achieve Double Digit Growth In FY25?Подробнее

Dr. Lal Pathlabs Earnings Call for Q2FY25Подробнее

Dr Lal Path Labs On Co’s Growth Rate | ET NOWПодробнее

Expansion into new territories to boost growth: Dr Lal PathLabsПодробнее

Dr Lal Pathlabs Q1 Earnings: Eyeing Double-Digit Volume Growth | Shankha Banerjee | ET NowПодробнее

Know All About Dr Lal Path Labs, SRL Diagnostics' IPO & Apollo Hospitals | The Medicine BoxПодробнее

What is HURTING Dr LAL PATHLABS & DIAGNOSTIC SECTOR ? Bubble in the Industry ?Подробнее

Dr Lal PathLabs CEO on expansion, competing with PE-backed players and moreПодробнее

The COVID-19 Effect on the Diagnostic IndustryПодробнее

Results Update | Dr Lal PathLabs | Stocks Update | Quarterly Performance #stockmarket #investПодробнее

Dr Lal Pathlabs Q3 growth sustainable? | CFO Ved Goel to ET NOWПодробнее

Dr Lal PathLabs Fundamental Analysis | Company | Business Model | Industry | IWPTПодробнее

Dr Lal Pathlabs: Q1, Margins, Expansion Plans & Capex | Dr. Om Manchanda Explains | Business NewsПодробнее

Dr Lal Path Labs, Fortis Healthcare & Apollo; Deep Dive Into Key Players Of Diagnostic BusinessПодробнее

Dr Lal Path labs | Fundamental analysisПодробнее